Table of Content

1. Service Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stem Cell Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Allogenic Transplants, Autologous Transplants)
5.2.2. By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells)
5.2.3. By Application (Cancer, Musculoskeletal Disorder, Wounds and Injuries, Cardiovascular Disease, Others)
5.2.4. By End User (Hospitals and Surgical Centres, Therapeutic Companies)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
6. North America Stem Cell Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Cell Source
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Stem Cell Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Cell Source
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Stem Cell Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Cell Source
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Stem Cell Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Cell Source
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Stem Cell Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Cell Source
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Stem Cell Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Cell Source
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. United Kingdom Stem Cell Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Cell Source
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Italy Stem Cell Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Type
7.3.3.2.2. By Cell Source
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. France Stem Cell Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Cell Source
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Stem Cell Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Cell Source
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Stem Cell Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Cell Source
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Stem Cell Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Cell Source
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Stem Cell Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Cell Source
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Stem Cell Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Cell Source
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Stem Cell Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Cell Source
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Stem Cell Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Cell Source
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Stem Cell Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Cell Source
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stem Cell Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Cell Source
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Stem Cell Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Cell Source
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Stem Cell Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Cell Source
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Stem Cell Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Cell Source
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stem Cell Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Cell Source
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Cell Source
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Stem Cell Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Cell Source
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
12. Market Trends & Developments
13. Global Stem Cell Therapy Market: SWOT Analysis
14. Competitive Landscape
14.1. Business Overview
14.2. Application Offerings
14.3. Recent Developments
14.4. Key Personnel
14.5. SWOT Analysis
14.5.1. Biorestorative Therapies Inc.
14.5.2. Celgene corporation
14.5.3. ReNeuron Group plc
14.5.4. Opexa Therapeutics, Inc.
14.5.5. Pluristem Therapeutics Inc
14.5.6. STEMCELL Technologies Inc.
14.5.7. Biovault family
14.5.8. Precious Cells International Ltd
14.5.9. Mesoblast Ltd
14.5.10. Seneca Biopharmaceuticals, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer